The recall involves one lot containing 96 units of Clobetasol Propionate Ointment USP, 0.05% packaged in 60 g aluminum tubes with polypropylene puncture-tip caps.

The types of Clobetasol included in the deal were: a cream, E cream, ointment, gel and topical solution. Clobetasol Propionate is used to treat diseases such as eczema and psoriasis, where it is ...

Dr. Reddy’s Laboratories announced that the Food and Drug Administration (FDA) has approved Impoyz (clobetasol propionate) Cream 0.025%, formerly DFD-06, for the treatment of moderate to severe ...

About Impoyz™ (clobetasol propionate) Cream, 0.025% Impoyz Cream is indicated for the treatment of moderate to severe plaque psoriasis in patients 18 years of age and older.

Impoyz (clobetasol propionate) Cream, 0.025% is a high potency topical steroid approved for the treatment of moderate to severe plaque psoriasis in patients 18 years of age or older.

He then started using calcipotriene ointment and clobetasol propionate ointment together twice a day. Three weeks later the plaques were much flatter and less erythematous.

Clobetasol propionate cream has a market value of approximately $57 million for the 12 months ending September 2019, according to IQVIA.

Dear Doctors: I have been diagnosed with inverse psoriasis in the area of my groin. My dermatologist has prescribed clobetasol propionate ointment to be used twice a day. The skin in that area ...

The patient's treatment was changed to doxepin 50 mg q.h.s., hydroxyzine 10 mg b.i.d., and 0.1% nitrogen mustard in Aquaphor base daily in addition to clobetasol propionate 0.05% cream b.i.d.

The patient’s only therapy at this time was topical clobetasol propionate ointment 0.05% applied twice daily and NB-UVB twice weekly. Ms. S reached a PASI score of >75% with the topical and NB ...

Aug 22 (Reuters) - Teligent IncBy Reuters August 22, 20171:59 PM UTCUpdated ago Aug 22 (Reuters) - Teligent Inc * Teligent Inc. Announces FDA approval of clobetasol propionate cream usp, 0.05 pct ...

* TELIGENT INC - RECEIVED APPROVAL OF CO'S ABBREVIATED NEW DRUG APPLICATION FROM U.S. FDA OF CLOBETASOL PROPIONATE CREAM USP, 0.05% Source text for Eikon: Further company coverage: ...